Learning Center
Plans & pricing Sign in
Sign Out
Get this document free

Disposable Surgical Drapes And G

VIEWS: 337 PAGES: 12

                                                           Issue 1 2010

      Disposable Surgical Drapes And Gowns
                                            Safety Is Our First Priority

                         Sharing Global Experiences
            Us Study On Post Operative Infections And Hospitalisation

                                            FREE PRIZE DRAW
The HARTMANN Group                          Win £30 M&S Vouchers
A History Based On People And Ideas

         to the 1st Edition of Theatre News

        T  his new journal from PAUL HARTMANN Limited aims to publish
           articles on topical issues for operating theatres and to share
        examples of operating theatre practice across the UK and worldwide.

        PAUL HARTMANN Limited, based in Heywood, Lancashire, is part of the
        HARTMANN Group, a company with a history of developing innovative
        healthcare products since 1818. The enclosed article charts the company’s
        progress from its humble beginnings to our global presence today.

        Our unique range of Foliodrape surgical disposable drapes and Foliodress
        surgical disposable gowns have been developed to offer a high degree of
        safety and to support effective infection control. The European Standard
        EN 13795 is explained within this issue, and is supported by information on
        how the material selection for HARTMANN products ensures that European
        standards of performance are exceeded.

        As part of our aim to share information on operating theatre practice
        across the world, our first issue of Operating Theatre News reviews a study
        of the University Hospital of Wisconsin, USA and the additional periods of
        hospitalisation and associated costs required for treating postoperative
        infections in surgery.

        Finally, please do complete the enclosed flyer for your chance to win £30 of
        Marks and Spencer vouchers and to receive FREE samples of our Foliodress
        Protect A Standard Gown.

        Enjoy this issue.

       K .Rawlinson
        Kim Rawlinson
        Business Development Manager
        Paul HARTMANN Ltd

See insert to enter our
and win £30 Marks and Spencer Vouchers

     1                                                  2                                               3

                   190 years of HARTMANN
                   A history based on people and ideas
                   190 years ago in Heidenheim, the head quarters of a company was established
                   which today enjoys global recognition for healthcare and hygiene products.
                   With almost 9,000 employees in 37 countries and sales of EUR 1.4 billion,
                   HARTMANN is amongst the leading companies in its industry.

    1) Paul HARTMANN’s humble bandage factory              Ludwig von HARTMANN created the basis      always deadly for people during this time.
    at the so-called “Scheckenbleiche” about 1900.     for this development in 1818, when he took     Sir Joseph Lister (1827-1912) is acknowledged
    On the right is the house of the family.           over a textile company on the River Brenz.     as the true pioneer, because of his
    2) View of the packing department in 1935. In
                                                       However, it was his son Paul HARTMANN          groundbreaking word on antisepsis.
    the foreground you can see mull rolls, which
                                                       Senior who set the company’s course in the         Alongside, this revolutionary advance
    are packed with the aid of the machines.
    Attention should be paid to the clean room
                                                       direction of medicine and recognised the       in surgery and wound treatment was the
    environment. The employees even had to wear        opportunities which lay in the industrial      invention of new dressing materials. To create
    hygienic headgear.                                 manufacture of absorbent cotton wool.          a new type of antiseptic wound dressing, Lister,
    3) HARTMANN Exhibition Stand at a medical                                                         for example, needed different materials which
    congress in Sevilla 1921. The Spanish branch       Pioneering Medical Developments in the         had not been used before. The new type of
    exhibited clinical equipment and surgical          19th Century                                   wound dressing, which was intended for use as
    instruments, which were sold as trading goods.         The 19th century is acknowledged as the    a wound contact layer, consisted of a piece of
                                                       beginning of huge advancements in medicine,    silk cloth coated with dextrin and impregnated
                                                       as it achieved more for humanity during this   with a solution of carbolic acid. It was covered
                                                       period than the thousands of years before.     by a secondary layer of fine gauze impregnated
    4) Ludwig von HARTMANN (1766-1852) is the
                                                       The victory over pain through etherisation     with carbolic acid, resin and paraffin, the
    councillor of commerce, who developed his
    factory into one of the biggest cotton mills.
                                                       and the new findings in bacteriology were      so-called Lister’s Carbolic Gauze. Another six
    5) His son Paul HARTMANN Senior (1812-             extremely important for medical progress.      layers placed on top of the first two ones were
    1884) was able to build upon the tradition of      These developments made it possible to fight   intended for absorbing exudate.
    his family and founded his own textile factory,    against infected wounds, which were almost         This helps us to understand why Lister
    which focused on the production of dressings.
    6) Prof. Victor von Bruns (1812-1883) developed,
    together with the chemist Johannes Schmid
    from Tuebingen, a procedure of removing grease
    from cotton.
    7) With his Carbolic Gauze Sir Joseph Lister
    (1827-1912) could achieve an important victory
    in the battle against infected wounds, which
    had limited the possibilities of surgery until
    this time.
                                                        4                       5                       6                        7

190 Years of HARTMANN
was very interested in the cost-effective          dressing, Branolind, specially designed to avoid sticking to
manufacture of Carbolic Gauze, in order to         the wound and thus reduce the pain of dressing changes. In
guarantee that his new method became               1964 Pur-Zellin, a perforated cellulose swab specially designed
widely accepted. So he sent a letter to Paul       to retain its shape, was launched and is still used in many
HARTMANN Senior in Heidenheim with                 GP surgeries today. In 1965 the safety in operating theatres
detailed instructions on 27 April 1874, which      was redefined due to an interwoven X-ray detectable thread
made it possible to begin industrial production    called Telatrast. In 1967 there was the first gauze compress
of this new type of dressing material. In the      with folded in cut edges, which is free from intrusive
year before, in 1873,                              threads around the edges. As ES-Kompresse,
    Paul HARTMANN Senior had already               it became a classic gauze
started with the industrial production of          swab in the treatment
absorbent cotton wool. Production was              of wounds. In 1974
based on the latest findings by surgeon            the incontinence insert
Prof. Dr. Victor von Bruns in Tübingen, who        pad MoliNea Plus D was
had developed a process of making raw              launched and paved the
cotton absorbent by removing grease from           way for the market entry
cotton wool through boiling it in a 4% soda        in continence care. In the
lye. Through the years, there have always          meantime HARTMANN
been dedicated partners from the fields of         became one of the leading
medicine, who have helped initiate product         companies in Europe with its
creations which were further developed             brands like MoliCare, MoliForm
                                                                                                                     Examples of products of the HARTMANN
by PAUL HARTMANN. Besides Carbolic                 and MoliMed continence
                                                                                                                     product range from several decades:
Gauze, this included other products such as        care products. In 1976 the                         development
                                                                                                                     8) Different tampons for use in
Protective-Silk, Carbolic Silk and Carbolic        of disposable drape sheets under                                  gynaecology (from the price list of 1909)
Catgut according to Lister, Carbolized Jute        the Folioplast brand laid the foundation for a whole new          9) The suture material Pehafil was proven
by Bardeleben, Esmarch’s Bandage, and              product area: disposable drape sheets designed to prevent         to be chemically and mechanically non-
Jodoform Gauze according to Mikulicz               infection.                                                        irritant (about 1960).
and Billroth’s evaporating turpentine oil              Dressings, hygiene and healthcare products support            10) Headgear supplied with easily
dressing. At the same time, there was another      the daily work of all health care professionals and perform       replaceable cellophane inserts to avoid
trailblazing innovation in the field of hygiene,   important therapeutic tasks. This is one of the reasons,          airborne infection (about 1960).
which laid the foundations for the production      why the history of HARTMANN is closely connected to               11) Scrubs with and without sleeves made
of modern hygiene products, namely Gustav          the progress of medicine and health care. So the dialogue         of strong cotton cloth or strong linen,
                                                                                                                     which certainly made the OP-team sweat
Walcher’s invention of highly absorbent            between science and practice has always been and will
                                                                                                                     (from the price list of 1909).
cellulose wadding that could be produced in a      remain an important part of the HARTMANN company
cost-effective manner.

People and their ideas
    In Germany there are only a few companies
which have a 190-year-old company history
and family history. After the death of Paul
HARTMANN, his son Paul HARTMANN junior
expanded the factory within 10 years into
a worldwide group with branches in most
industrialised countries. In 1912 Walter
HARTMANN, Paul HARTMANN Junior’s eldest
son, reorganised the expanding company into
a public limited company with the family still
                                                    8                                                                  9
in sole control. New product areas emerged
and the Heidenheim factory began producing
adhesive plasters and lotions developed             10                                       11
in the recently completed pharmaceutical
    In 1936 the HARTMANN brand became
increasingly familiar to consumers thanks to
contemporary advertising and a catchy slogan
“HARTMANN helps healing” which remains
the Group slogan today.
    A raft of innovative product developments
shaped the following years. For example: in
1938 HARTMANN developed its first ointment

    Products and Services                                                                  

                            HARTMANN disposable
                            operating theatre systems
                            A Safety First Approach
                            Today’s high operating theatre standards stand and fall with
                            the hygienic measures that are adopted for the prevention of
                            infection. Sterile draping of the patient, their surroundings
                            and the wearing of sterile operating theatre clothing are
                            essential components of effective infection control.
                            THERE CAN BE NO COMPROMISE ON SAFETY. However, safety
                            does not preclude economy, as demonstrated by HARTMANN
                            disposable operating theatre systems.

                                Draping materials and operating theatre                high level of protection against infection are
                            clothing are used to protect against infections and        certainly the most important of many reasons
                            are therefore regarded legally as medical products.        why draping materials and operating theatre
                                Their production and quality testing are               clothing made of nonwoven fabric are often
                            subject to European Standard EN 13795. The                 preferred to reusable textile systems. Moreover,
                            most important test methods relate to the                  the reprocessing of reusable textile systems is a
                            material properties which are essential for                sophisticated, cost-intensive undertaking.
                              reliable protection against infection:
                               • Particle release (linting) (ISO 9073-10),             Two European Standard
                                 • Resistance to liquid penetration                    performance levels
                                    (European Standard EN 20811)                       Part 3 of European standard EN 13795,
                                   • Wet microbial penetration                         published in August 2006, among other
                                        (European Standard EN ISO 22610).              things classifies medical products in two
                                      Nonwoven fabrics – especially the                performance levels: High Performance and
                                       innovative Spunbound-Meltblown-                 Standard Performance.
                                         Spunbound material (SMS), from                    According to the requirements of these
                                          which HARTMANN operating                     performance levels, HARTMANN can provide
                                            theatre clothing are manufactured          different material qualities and product
                                             – and the composite materials             designs, to respond to the risk of infection
                                             from film and nonwoven for                specific to surgery. If, for example, the
                                          the surgical drapes, fulfil these            operation is only of short duration and large
                                       requirements perfectly.                         amounts of body fluids are not to be expected,
                                    Material safety and the associated                 for sterile draping it is possible to use a
                                                                                       cost-effective, but always protective two-layer
                                                                                       material instead of a three-layer material.
                            Not every operation has the same risk of infection. This
                                                                                           Furthermore, HARTMANN can also meet
                            means that draping materials and operating theatre
                            clothing can only be used economically when they
                                                                                       the various hygienic requirements for individual
                            correspond exactly to the respective surgery-specific      operations with special product designs.
                            requirements in material quality and product design.       A good example of this is the disposable
                            HARTMANN disposable operating theatre systems offer        surgical gown Foliodress gown urology. In
                            economical alternatives at the highest level of safety.    urological operations, there are very large

HARTMANN disposable operating theatre systems
amounts of body fluids, therefore the gown is        moisture and bacteria migration. Owing to the
provided with a fluid impermeable PE film under      firm bonding of the fibres, it is particularly low-
                                                                                                               1                                                    A
the chest area, for reliable protection of the       linting and abrasion-resistant, yet extremely
surgeon against potentially infectious material      soft and breathable, providing excellent                  2
and fluids.                                          wearing comfort.
   Accordingly, the HARTMANN range                       HARTMANN have a gown tailored to the
of disposable operating theatre products             particular needs of the procedure with its                3
includes a large number of products in various       three product lines:
materials and designs, which meet both               Foliodress Protect – available in reinforced
the high hygienic requirements for effective         NEW Foliodress Protect A – available in                   4                                                    B
protection against infection and the necessary       standard
economic concerns.                                   Foliodress gown Comfort - available in
                                                     reinforced and standard                                   5
Foliodrape surgical drapes – two material                For example, Foliodress gown Protect A
variants for all cases                               Standard is suitable for operations of shorter
   The fact that Foliodrape functions so well        procedures involving small quantities of fluid.
not only as a reliable barrier to infection, but     Foliodress Protect Reinforced has reinforced
also with respect to economical use, is due to       sleeves and chest area and is suitable for             A) Foliodrape Comfort, three-layer, with an outermost
the two different material variants Foliodrape       longer operations involving moderate to large          low-particle viscose-nonwoven in 3D “orange skin
Comfort and Foliodrape Protect:                      quantities of fluids.                                  structure” (1) for rapid absorption of fluids, an absolutely
• The three-layer material of Foliodrape                 The range is completed by the Foliodress           germproof intermediate layer of polyethylene film (2) and
Comfort is designed for all operations of            operating scrub theatre clothing. It consists          the bottom layer of a soft polypropylene nonwoven (3) for
long duration and for operations involving           of tunic and trousers and also complies                greater patient comfort.
large amounts of body fluids. The material           with European Standard EN 13795. With its
properties of Foliodrape Comfort exceed all          very attractive price, it also contributes to          B) Foliodrape Protect, two-layer, consisting of a lower
high-performance requirements in European            economical use.                                        impermeable layer of polyethylene film (5) and an SMS
                                                                                                            (Spunbound – Meltblown – Spunbound) surface layer
standard EN 13795.
                                                     Below: Some examples from the large Foliodrape         (4), which binds fluid quickly, drapes well and has a low
• The two-layer material of Foliodrape
                                                     and Foliodress range. The individual products can be   number of particles.
Protect is designed for short operations in
                                                     assembled in the Foliodrape CombiSets as required.
the inpatient and outpatient area, involving
small amounts of body fluids. The material
properties of Foliodrape Protect also meet all
high-performance requirements in European
standard EN 13795.
   In addition, there are also a great variety of
Foliodrape drapes, which makes a substantial
contribution to economical use. The available
products include complete sets for frequent
surgical indications, special drapes.

 Foliodress operating theatre clothing
– always to be used economically
Also for the Foliodress range of disposable
surgical gowns and disposable operating
theatre scrub clothing, without detriment to
safety and wearing comfort it is always possible
to select operating theatre clothing that is
adequate for the hygienic requirements of the
planned operation. This saves costs. Of course,
all products comply with standard EN 13795 (1-
3) of the European Standard for surgical gowns
and operating theatre clothing.
     Foliodress disposable surgical gowns are
made from the innovative SMS (Spunbound
– Meltblown – Spunbound) -nonwoven
polypropylene fabric, which guarantees
optimum quality: the nonwoven fabric material
is fluid-repellent and provides high resistance to

    Medicine and Sciences                                                                                                     

    The costs of postoperative infections
    Additional periods of hospitalisation
    are expensive
                                                        A study of the University Hospital of Wisconsin, USA,
                                                        shows that the additional period of hospitalisation
                                                        that is required for treating postoperative infections
                                                        in surgery represents a decisive cost factor.
                                                        A correlation between period of hospitalisation and
                                                        costs on the one hand, and the localisation of the
                                                        infection on the other, can also be demonstrated.
                                                        A contribution from Hardy-Thorsten Panknin, Badensche Straße 49, D-10715 Berlin Germany

                                                        Co-author: Prof. Dr. med. Bernd Reith, Chief Physician of the Surgical Clinic, Klinikum Konstanz
                                                        (Constance Hospital), Luisenstraße 7, D-78464 Konstanz Germany

                                  Even with careful observance of hygiene standards and                 therapeutic measures and leading in some circumstances to
                              execution of the usual antibiotic prophylaxis, after elective             secondary injuries. For the hospital, postoperative infections
                              surgical procedures there is infection at the surgical site               on the one hand mean a recognisable quality problem, and
                              in approx. 1-5 % of cases. For the patients affected this                 on the other hand, the necessary follow-up treatments lead
                              means prolongation of their pain and functional restrictions              to increased costs. Hospital managements should therefore
                              – even if there are no more serious consequences, such as                 at least determine how the costs arising from individual
                              reoperations, losses of limbs or organs or in the worst case,             complications are correlated, so that the preventive
                              death owing to uncontrollable infection.                                  measures provided by the hygiene team can be directed first
                                  As well as surgical site infections, however, other                   at the most cost-intensive infections.
                              infectious complications are also possible. Urinary
                              catheterisation that is often associated with surgery can                 Wound infections and other infections in the
                              lead to a nosocomial urinary tract infection, and prolonged               postoperative phase
                              assisted ventilation in the intensive care unit can lead to               An American study with a large number of surgical
                              ventilator-associated pneumonia. Such complications also                  patients aimed to analyse the costs of postoperative
                              prolong hospitalisation, necessitating further diagnostic and             surgical site infections (“wound infections”) in relation to
                                                                                                        other nosocomial infections in the postoperative phase.
    Prolongation of hospitalisation                                                      Table 1        The data originated from a study that was carried out
                                        Period of hospitalisation in days                               towards the end of the 1990s at the University Hospital
                                        (25th-75th percentile)                                          of Wisconsin, USA, the original purpose of which was
                                                                                                        to evaluate the effect of nasal decolonisation treatment
                                        Patients with non-         Patients with fatal
                                                                                                        with mupirocin on the postoperative infection rate. At
                                        fatal underlying           underlying disease
                                                                                                        that time, the data showed only a very limited effect of
    Infection type                      disease
                                                                                                        such decolonisation treatment, so that general mupirocin
    Surgical site infection             8 (5-13)                   8 (5-14)                             prophylaxis can be considered since then as out-dated.
    Nosocomial infection at some        10 (6-21)                  8 (5-14)                             The extensive clinical data was then used again in 2006,
    other site                                                                                          to evaluate the relations between the pre-operative
    No infection                        5 (3-7)                    5 (3-7)                              pathological state and subsequent infectious complications

The costs of postoperative infections
(Herwaldt LA et al., A prospective study of outcomes,             Conclusions
healthcare resource utilisation, and costs associated with        Postoperative infections in surgical patients lead to a prolongation of hospitalisation
postoperative nosocomial infections. Infect Control Hosp          of on average 3-5 days, and the patient’s underlying disease (fatal, non-fatal)
Epidemiol 2006;27:1291-1298).                                     does not play a large role. What is decisive for the degree of prolongation of
                                                                  hospitalisation is rather the question whether the infection is at the surgical site or
Results                                                           whether it is a nosocomial infection at some other site (e.g. ventilator-associated
Of the 3,864 patients who were included in the mupirocin          pneumonia, septicaemia). The costs were also significantly higher for infections that
study, 2,408 (62.3 %) underwent general surgery,                  did not relate to the surgical site.
732 (18.9 %) underwent neurosurgery and 724 (18.7
%) underwent cardiac surgery. Postoperatively, 438                The study uncovers two interesting aspects: on the one hand, the average
(11.3 %) patients developed at least one nosocomial               prolongation of hospitalisation was not as pronounced as would be expected with
infection. 316 of these infections were postoperative             severe infections. One possible reason for this is that the outpatient sector and
surgical site infections, and in addition there were 54           the inpatient sector are closely interlinked in the US-American health care system,
urinary tract infections, 43 respiratory tract infections         so that even if there is a continuing need for therapy (antibiotics, laboratory tests,
and 18 septicaemias. The commonest pathogens were                 X-rays) the patient can be discharged – as a rule in the hospital’s own outpatient
staphylococci, at 40% of all isolates. 11 of the 438              department. In this way, the primary carers do not lose contact with the patient and
patients with nosocomial infection (2.5 %) died. The              can if necessary arrange for readmission, if the infection does not subside. On the
mortality of these infected patients was far higher than for      other hand, it was clear from the study that infections away from the surgical site
patients without infection (45 of 3,425 = 1.3 %), but the         cost considerably more than surgical “wound infections”.
difference was not statistically significant.
                                                                  The explanation is presumably that ventilator-associated pneumonias and
Costs of treatment for postoperative infections                   septicaemias associated with venous catheters as a general rule develop during
The authors also investigated the direct costs of treatment       therapy in intensive care units and therefore the prolongation of hospitalisation
for postoperative infections. Such a cost analysis is easier in   takes place in the (more expensive) intensive care unit. Presumably, therefore, those
the US-American health care system, because each individual       patients are affected who already have underlying diseases that are more prone to
therapeutic measure is charged to the health insurer. In          complications; however, this relationship was not analysed in detail by the authors.
addition, the prolonged period of hospitalisation makes a
difference to the respective daily basic charge (Table 1).        However, what is important for hygiene management is the conclusion that
    It was found that the period of hospitalisation for           infections such as ventilator-associated pneumonias and septicaemias associated
nosocomial infection away from the surgical site was, at an       with venous catheters are presumably the largest cost factors and therefore hygiene
average of 10 days, significantly longer than for patients        regimens should take precedence in the prevention of such complications.
with postoperative surgical site infection (average period
of hospitalisation 8 days) and relative to patients without        Percentage cost increase                                                               Table 2
infection (average period of hospitalisation 5 days, in                                                   Cost increase in % ± standard error*
each case p < 0.001). For patients with fatal underlying
                                                                                                          Surgical site infection     Infection at some
disease the prolongation of hospitalisation was the same
                                                                                                          (“surgical wound            other site
with both types of infection. An important observation
                                                                   Type of surgery                        infection”)
was that ultimately the prolongation of hospitalisation for
patients with fatal underlying diseases was no greater than        General surgery                        82.9 ± 16.7 (s)             344.2 ± 68.3 (s)
for patients with other underlying diseases or without an          Non-fatal underlying disease           105.6 ± 23.9 (s)            171.1 ± 46.8 (s)
underlying disease.                                                Fatal underlying disease
    Owing to the prolongation of hospitalisation, but also         Cardiac / thoracic surgery             25.2 ± 13.8 (ns)            95.9 ± 34.8 (s)
owing to the diagnostic and therapeutic measures in                Non-fatal underlying disease           40.8 ± 22.1 (ns)            19.5 ± 27.3 (ns)
connection with the infections, there were marked cost             Fatal underlying disease
increases, shown as relative values in Table 2. It can be          Neurosurgery                           60.8 ± 32.1 (ns)            306.7 ± 90.5 (s)
seen that infections away from the surgical site, both in          Non-fatal underlying disease           80.9 ± 42.2 (ns)            148.2 ± 67.1 (s)
general surgery and in cardiac surgery and neurosurgery,           Fatal underlying disease
were much more expensive than surgical site infections.
    It was only in the case of cardiac surgery patients with
fatal underlying diseases that such a difference could not        * the hospital costs for a 45-year-old patient of normal weight without underlying diseases,
be demonstrated. For some subgroups (e.g. general surgery,        without pre-operative infection and with a pre-operative period of hospitalisation of 1 day were
infection away from the surgical site), the cost increases        taken as the reference value. These “reference costs” came to 1,899 US-$ for general surgery,
reached values up to 344 % above the reference costs for a        3,400 US-$ for cardiac or thoracic surgery and 2,226 US-$ for neurosurgery.
45-year-old, healthy comparative patient with the same type       s = significant cost increase relative to reference value, ns = cost increase not significant
of surgery, but without postoperative infection.

     Hydrofilm® Plus
     High MVTR Transparent film dressing
     with absorbent pad.
     Reliable protection of exuding wounds.
     By introducing Hydrofilm® Plus, HARTMANN have complimented their range of modern and traditional wound care products with
     a cost effective, self adhesive, transparent film dressing with pad, which exactly meets the needs of post op wound management.

     The pad itself is Cosmopor® E – viscose fibres coated with an anti-adherent polyethylene net.

     Application - Easy as 1, 2, 3, 4
                                                                          PRO® E
     With its four stage application process Hydrofilm® Plus
     makes for simple, time saving application.
                                                                    WATE opor
     Strong yet Sensitive                                             Cosm
     The acrylic, hypoallergenic adhesive provides
     maximum security, whilst being tolerated by patients
                                                                For further information: Telephone 01706 363200,
     with sensitive skin. The polyurethane film material is
     extremely thin and elastic which means the dressing
     will adapt to body contours and can be removed
     painlessly without damaging new epithelium.                www.HARTMANN.

Great Britain Website
A new year brings a new look to the HARTMANN Great Britain
website, which has been redesigned to promote our extensive
range of products and added value services. The new look
website can be viewed at

You can search for detailed product information by selecting the appropriate
product category (Wound Management, Continence Management and
Operating Theatre Products) and then selecting Unique Products. In addition,
why not download HARTMANN publications, literature and clinical studies
direct from the website.

We would welcome your comments on the new website and your
suggestions for its further development. Please send your comments to

Denise Murray joins the HARTMANN
Operating Theatre Products Division
                                                   We are pleased to confirm that Denise Murray has joined the
                                                   Operating Theatre Products Division of PAUL HARTMANN Limited.
                                                   As Territory Sales Manager, Denise will cover the North West Territory
                                                   promoting our unique range of disposable operating theatre surgical
                                                   drapes and theatre clothing. Christopher Boaler has undertaken this
                                                   role previously but will now become the North West Territory Sales
                                                   Manager for the Wound Management Division.

                                                   Denise qualified as a nurse in 1983 at Salford Health Authority and commenced her
                                                   career as a scrub nurse covering many specialties. Denise comments “I wanted to
                                                   work for HARTMANN as it is such a well established company with a long history
                                                   and worldwide presence. There are many unique products and some interesting
                                                   innovations which as an ex-theatre nurse, I would love to have access to. This new
                                                   position enables me to combine my theatre experience with the product knowledge
                                                   of our extensive range. My aim is to be recognised as the face of HARTMANN for
                                                   operating theatre products in the North West and for my customers to believe that I
                                                   will go the extra mile to meet their needs”.

                                                   We wish Denise every success at PAUL HARTMANN Limited as we believe she will
                                                   become an invaluable support to our existing and new customers.

                                                   Denise Murray can be contacted on 07967 676335 or by email at

Working together to make a difference

Risk prevention requires a team effort
The risk of infection during surgical procedures places a heavy responsibility on
surgeons, operating department practitioners and theatre staff.

Hence the need for a professional partner able to supply high quality protective
materials designed to maximise patient care and protect theatre staff.

At HARTMANN, our theatre products are based on innovative, patented technology,
which combines maximum infection control with time-saving practicality. As a key
supplier to the NHS, our full range of drapes and gowns are available on national
contract, making them easy to obtain as well as reliable and effective.

PAUL HARTMANN Limited, Heywood Distribution Park, Pilsworth Road, Heywood, Lancashire. 0L10 2TT
Tel: 01706 363200 Fax: 01706 363201 Web: E-mail:

To top